US Broker Ratings

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 486% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Upstream Bio, Inc. (NASDAQ: UPB) an intriguing prospect, especially given its substantial potential upside of 486.49%...

Standard BioTools Inc. (LAB) Stock Analysis: Potential Upside with a Target Price of $1.35

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector with a focus on medical devices, is drawing attention from investors with a noteworthy potential..

Humacyte, Inc. (HUMA) Stock Analysis: Unpacking a 221.68% Potential Upside in the Biotech Arena

Investors navigating the volatile waters of the biotechnology sector may want to give Humacyte, Inc. (NASDAQ: HUMA) a closer look. With a promising potential upside of..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Unpacking a 56.7% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, is capturing investor attention with its significant potential upside of 56.7%. Specializing in preparedness..

RxSight, Inc. (RXST) Stock Analysis: Evaluating the 46% Potential Upside in Medical Device Innovation

RxSight, Inc. (RXST), a pioneering player in the medical devices sector, offers investors a unique proposition with its innovative approach to cataract surgery solutions. Specializing in..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Exploring a 60.60% Potential Upside in Biotechnology

Stoke Therapeutics, Inc. (NASDAQ: STOK) is making waves in the biotechnology sector with its innovative approach to developing treatments for severe genetic diseases. Based in Bedford,..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Gem with a 34% Upside Potential

AbCellera Biologics Inc. (NASDAQ: ABCL) continues to capture investor attention due to its promising potential in the biotechnology sector. Based in Vancouver, Canada, this innovative company..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unveiling a 21.41% Upside Potential

Investors with an eye on the healthcare sector, particularly those interested in medical devices, might find Treace Medical Concepts, Inc. (NASDAQ: TMCI) an intriguing prospect. This..

Arvinas, Inc. (ARVN) Stock Analysis: Uncovering a Potential 67.61% Upside in the Biotech Sector

Arvinas, Inc. (NASDAQ: ARVN), a prominent player in the biotechnology industry, is drawing attention from investors due to its innovative approach to drug development and a..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges in the Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering a robust platform for cell engineering. Despite its promising technological capabilities,..

Dianthus Therapeutics (DNTH) Stock Analysis: Exploring a 39% Potential Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has captured the spotlight in the biotechnology industry with its impressive growth trajectory and a compelling potential upside of 39.24%. As..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 151.94% Upside in the Biotech Sector

For investors with a keen interest in the burgeoning field of gene therapy, Taysha Gene Therapies, Inc. (NASDAQ: TSHA) offers a compelling opportunity. With a market..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A 166.83% Potential Upside in the Biotech Arena

Individual investors seeking to capitalize on the growth potential within the biotechnology sector may find Maze Therapeutics, Inc. (NASDAQ: MAZE) an intriguing opportunity. With a market..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech Gem with 111% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has emerged as a compelling player in the healthcare sector, particularly within the biotechnology industry. The company, based in Boston, Massachusetts,..

Precigen, Inc. (PGEN) Stock Analysis: A 84% Upside Potential Sparks Investor Interest

Investors looking for promising opportunities in the biotechnology sector may want to turn their attention to Precigen, Inc. (NASDAQ: PGEN), a company at the forefront of..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a 158% Potential Upside in the Biotech Sector

Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with its innovative approach to addressing diseases underserved by current treatments. Based in Cambridge, United..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Challenges in Diagnostics & Research

Myriad Genetics, Inc. (MYGN), a prominent player in the healthcare sector, particularly in diagnostics and research, is navigating a challenging financial landscape. With a market capitalization..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a 337% Potential Upside

Investors with an eye on the healthcare sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing prospect. Operating in the niche of drug manufacturing, particularly..

Verastem, Inc. (VSTM) Stock Analysis: Unveiling a 94% Potential Upside in the Biotech Arena

Verastem, Inc. (NASDAQ: VSTM), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising potential upside of 94.26%. Specializing in..

Inventiva S.A. (IVA): Analyst Ratings Signal a 297% Upside Potential for Biotech Innovator

Inventiva S.A. – American Depositary Shares (IVA) represents a compelling opportunity for investors seeking exposure to a high-risk, high-reward segment of the biotech industry. Specializing in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds